Notes on Interval Estimation of the Generalized Odds Ratio Under Stratified Random Sampling

By Lui Kung-Jong  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 3, 2013-05 ,pp. : 513-525

Taylor & Francis Ltd

Access to resources Recommend Favorite

Evaluating and Adjusting for Premature Censoring of Progression-Free Survival

By Rothmann Mark   Koti Kallappa   Lee Kyung Yul   Lu Hong Laura   Shen Yuan Li   Zhang Jenny J.   Jin Mei   Zhou Haojin  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 5, 2013-09 ,pp. : 1091-1105

Taylor & Francis Ltd

Access to resources Recommend Favorite

Missing Data and Censoring in the Analysis of Progression-Free Survival in Oncology Clinical Trials

By Denne J. S.   Stone A. M.   Bailey-Iacona R.   Chen T.-T.  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 5, 2013-09 ,pp. : 951-970

Taylor & Francis Ltd

Access to resources Recommend Favorite

Maximum A Posteriori Bayesian Estimation of Mycophenolic Acid Area Under the Concentration-Time Curve: Is This Clinically Useful for Dosage Prediction Yet?

By Staatz Christine E.   Tett Susan E.  

Clinical Pharmacokinetics, Vol. 50, Iss. 12, 2011-12 ,pp. : 759-772

Adis International

Access to resources Recommend Favorite

Strength of Evidence of Noninferiority Trials with the Two Confidence Interval Method with Random Margin

By Wang So-Young  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 2, 2013-03 ,pp. : 307-321

Taylor & Francis Ltd

Access to resources Recommend Favorite